Nuklearmedizin 2019; 58(02): 194
DOI: 10.1055/s-0039-1683740
Georg Thieme Verlag KG Stuttgart · New York
Lu-177-PSMA-617 radioligand therapy in mCRPC patients with a single functioning kidney
J Zhang
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
HR Kulkarni
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
A Singh
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
C Schuchardt
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
K Niepsch
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
T Langbein
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
,
RP Baum
1
Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka
› Institutsangaben
